{"abstract": "Carl Icahn remains busy, and once again he is targeting a pharmaceutical company, Amylin. ", "web_url": "https://dealbook.nytimes.com/2009/04/20/icahn-amylin-and-the-new-nuances-of-activist-investing/", "snippet": "", "lead_paragraph": "Carl Icahn remains busy, and once again he is targeting a pharmaceutical company, Amylin. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Icahn, Amylin and the New Nuances of Activist Investing", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-04-20T14:31:18+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/54c3a205-2e56-5254-a7f9-07d39a4cdd7c", "word_count": 1468, "uri": "nyt://article/54c3a205-2e56-5254-a7f9-07d39a4cdd7c"}